|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.000 AUD | -1.48% |
|
-7.41% | -7.83% |
| 16/01 | Orthocell Finalizes Agreement With Biotechnology Company | MT |
| 16/01 | Orthocell finalises strategic investment in Marine Biomedica | RE |
Projected Income Statement: Orthocell Limited
Annual
Quarterly
Halfyear
Annual
Quarterly
Halfyear
| Fiscal Period: June | 2022 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Net sales 1 | - | - | 13.9 | 24.1 | 47.8 |
| Change | - | - | - | 73.38% | 98.34% |
| EBITDA 1 | - | - | -11.9 | -7 | 2.3 |
| Change | - | - | - | 41.18% | 132.86% |
| EBIT 1 | - | - | -13.2 | -8.8 | -0.1 |
| Change | - | - | - | 33.33% | 98.86% |
| Interest Paid | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Change | - | - | - | - | - |
| Net income | -9.107 | -8.567 | - | - | - |
| Change | - | - | - | - | - |
| Announcement Date | 30/08/22 | 29/08/25 | - | - | - |
1AUD in Million
Estimates
Forecast Balance Sheet: Orthocell Limited
| Fiscal Period: June | 2022 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | -43.7 | -36.1 | -31.3 |
| Change | - | - | - | 17.39% | 13.3% |
| Announcement Date | 30/08/22 | 29/08/25 | - | - | - |
1AUD in Million
Estimates
Cash Flow Forecast: Orthocell Limited
| Fiscal Period: June | 2026 | 2027 | 2028 |
|---|---|---|---|
| CAPEX 1 | 2 | 2 | 5 |
| Change | - | 0% | 150% |
| Free Cash Flow (FCF) 1 | -12.5 | -8.6 | -5.6 |
| Change | - | 31.2% | 34.88% |
| Announcement Date | - | - | - |
1AUD in Million
Estimates
Forecast Financial Ratios: Orthocell Limited
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
| EBITDA Margin (%) | - | - | - | - | - | - | -85.61% | -29.05% | 4.81% |
| EBIT Margin (%) | - | - | - | - | - | - | -94.96% | -36.51% | -0.21% |
| EBT Margin (%) | - | - | - | - | - | - | - | - | - |
| Net margin (%) | - | - | - | - | - | - | - | - | - |
| FCF margin (%) | - | - | - | - | - | - | -89.93% | -35.68% | -11.72% |
| FCF / Net Income (%) | - | - | - | - | - | - | - | - | - |
Profitability | |||||||||
| ROA | - | - | - | - | - | - | -15% | -7% | 8% |
| ROE | - | - | - | - | - | - | -24% | -12% | 13% |
Financial Health | |||||||||
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - | - |
| Debt / Free cash flow | - | - | - | - | - | - | - | - | - |
Capital Intensity | |||||||||
| CAPEX / Current Assets (%) | - | - | - | - | - | - | 14.39% | 8.3% | 10.46% |
| CAPEX / EBITDA (%) | - | - | - | - | - | - | -16.81% | -28.57% | 217.39% |
| CAPEX / FCF (%) | - | - | - | - | - | - | -16% | -23.26% | -89.29% |
Items per share | |||||||||
| Cash flow per share 1 | 0.1107 | 0.0857 | 0.0559 | 0.1258 | 0.0985 | 0.1176 | - | - | - |
| Change | - | -22.59% | -34.74% | 124.98% | -21.71% | 19.43% | - | - | - |
| Dividend per Share 1 | - | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - | - |
| Book Value Per Share 1 | 0.1132 | 0.0885 | 0.0502 | 0.0312 | 0.0217 | 0.0599 | - | - | - |
| Change | - | -21.77% | -43.25% | -37.97% | -30.52% | 176.49% | - | - | - |
| EPS 1 | -0.036 | -0.0484 | -0.047 | -0.032 | -0.036 | -0.0384 | - | - | - |
| Change | - | -34.34% | 2.82% | 31.91% | -12.5% | -6.59% | - | - | - |
| Nbr of stocks (in thousands) | 1,84,699 | 1,90,584 | 1,97,128 | 1,97,303 | 2,09,327 | 2,43,344 | - | - | - |
| Announcement Date | 31/08/20 | 27/08/21 | 30/08/22 | 31/08/23 | 30/08/24 | 29/08/25 | - | - | - |
1AUD
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E ratio | - | - |
| PBR | - | - |
| EV / Sales | 16.4x | 9.76x |
| Yield | - | - |
More valuation ratios
* Estimated data
EPS & Dividend
Y-o-Y evolution of P/E
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.000AUD
Average target price
1.330AUD
Spread / Average Target
+33.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OCC Stock
- Financials Orthocell Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















